Antimicrobial Peptides Neutralizing Endotoxin
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The increasing occurrence of antibiotic-resistant bacteria and the challenge of antibiotic treatment for Gram-negative infections, which can lead to septic shock due to the release of endotoxin, necessitates the development of antimicrobial agents with endotoxin-neutralizing properties.
Innovation Solution
Development of novel peptides and lipopeptides with specific amino acid sequences, such as (Xaa1)M-Trp(Xaa4)p-Arg(Xaa7)R(Arg)s, that exhibit antimicrobial and endotoxin-neutralizing activities, which can be used alone or in combination with conventional antibiotics to enhance treatment efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat Gram-negative infections, then bacterial growth is inhibited, but endotoxin is released from dying bacteria which triggers septic shock
Solution Approach 1:
The patent combines two functions into a single peptide molecule: antimicrobial activity (killing bacteria) and endotoxin-neutralizing activity (binding LPS). This merging resolves the contradiction by ensuring that when bacteria are killed, the released endotoxin is already neutralized by the same peptide, preventing septic shock while maintaining effective bacterial killing
Solution Approach 2:
The peptides are designed to perform multiple functions simultaneously: they act as antimicrobial agents against bacteria and as endotoxin neutralizers against LPS. This multi-functionality allows a single agent to address both the bacterial infection and the harmful endotoxin release, resolving the contradiction between effective killing and harmful byproduct generation
2Productivity
If antibiotics are administered to kill bacteria, then infection is treated, but rapid emergence of bacterial resistance occurs
Solution Approach 1:
The patent employs peptides with fundamentally different mechanisms of action compared to conventional antibiotics. Instead of targeting specific bacterial metabolic pathways that bacteria can mutate to resist, the peptides use membrane disruption and endotoxin neutralization mechanisms that are harder for bacteria to develop resistance against, thus maintaining treatment effectiveness while reducing resistance emergence
Solution Approach 2:
The peptides represent a composite approach combining amino acid sequences that confer both antimicrobial properties and endotoxin-binding capabilities. This composite structure creates a novel class of antimicrobial agents with dual functionality, addressing both the need for effective treatment and the concern about resistance development through mechanistic novelty
3Reliability
If host-defense peptides are used to kill bacteria instantly, then antimicrobial activity is enhanced, but the complexity of peptide design and synthesis increases
Solution Approach 1:
The patent designs peptides with segmented functional domains: N-terminal regions that provide antimicrobial activity through membrane interaction and C-terminal or side-chain regions that provide endotoxin-binding capability. This segmentation allows the peptide to achieve rapid killing through simple membrane disruption mechanisms while incorporating endotoxin neutralization, balancing effectiveness with design manageability
Solution Approach 2:
The peptides incorporate specific local structural features at key positions: hydrophobic residues at the N-terminus for membrane insertion and cationic residues for electrostatic interaction with LPS. This local quality approach allows the overall peptide structure to remain relatively simple while achieving complex dual functionality through strategically placed amino acid residues with specific properties
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These peptides demonstrate broad-spectrum activity against various pathogens, including bacteria, viruses, and fungi, effectively inhibiting microbial growth and neutralizing endotoxin, thereby reducing the risk of septic shock and overcoming antibiotic resistance.
Implementation Method 1
A variety of antimicrobial peptides also block the interaction of LPS with its receptors such as LBP, CD14 and MD-2/TLR4, resulting in inhibition of activation of macrophages
Implementation Method 2
The relevance of hydrophobicity and particularly of the presence of alkyl or acyl chains of lipopeptides for their anti-microbial activity has been described
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
The present invention relates to peptides with antimicrobial or endotoxin-neutralizing activity.